Asimov empowers the creation of previously impossible biotechnologies. The company's design platform enables them to precisely engineer genetic circuits for customers in diverse sectors. The company was founded by four biological engineering pioneers, Massachusetts Institute of Technology Professor Christopher Voigt, Boston University Professor Douglas Densmore, and MIT Biological Engineering Ph.D.s Alec Nielsen and Raja Srinivas.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/21/17 | $4,700,000 | Seed |
AME Cloud Ventures Data Collective Pillar | undisclosed |
